ROSA SINGLETON: Open Payments
NPI 1578883039 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 12 payments from 9 companies in 2025. Trend: 2023 $381 · 2024 $635 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Incyte Corporation | 1 | $35 |
| ABBVIE INC. | 2 | $35 |
| Lilly USA, LLC | 1 | $33 |
| Organon LLC | 1 | $23 |
| LEO Pharma Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: AFFINITY, DUPIXENT, Opzelura, EBGLYSS, VTAMA, ADBRY, RINVOQ, Sotyktu.
Industry payments across FL — which companies pay providers there.
